Breaking News Instant updates and real-time market news.

HALO

Halozyme

$17.02

-0.21 (-1.22%)

16:03
05/07/19
05/07
16:03
05/07/19
16:03

Halozyme reports Q1 EPS 1c, consensus 1c

Reports Q1 revenue $56.9M, consensus $67.8M. Reports cash, cash equivalents and marketable securities were $328.7M at March 31 compared to $354.5M at December 31, 2018. The company announced with regard to HALO-301, a Phase 3 study evaluating PEGPH20 in metastatic pancreas cancer, the company now expects to achieve the target number of overall survival events in the Q3.

  • 07

    May

  • 22

    May

  • 23

    May

  • 31

    May

HALO Halozyme
$17.02

-0.21 (-1.22%)

11/27/18
JEFF
11/27/18
NO CHANGE
Target $9
JEFF
Underperform
Jefferies still sees low likelihood of success for Halozyme's PEGPH20
Following the announced change in the Phase 3 endpoint, Jefferies analyst Eun Yang continues to view probability for success of Halozyme Therapeutics's PEGPH20 in pancreatic cancer as low. The change in the HALO-301 endpoint/data analysis "dampens our confidence further," Yang tells investors in a research note. HALO-301 is a phase 3 global, randomized, double-blind placebo controlled clinical trial evaluating investigational new drug PEGPH20 as a first-line therapy for potential treatment of patients with metastatic pancreas cancer. The analyst remains cautious on Halozyme shares with an Underpeform rating and $9 price target.
11/27/18
JMPS
11/27/18
NO CHANGE
Target $21
JMPS
Outperform
Halozyme Phase 3 trial amendment makes sense, says JMP Securities
After Halozyme announced that it is amending the design of the Phase 3 trial evaluating PEGPH20 in front-line pancreatic cancer to make overall survival the sole primary endpoint, JMP Securities analyst Jason Butler said he thinks the change makes sense and is neutral to his thesis. While the change pushes out first results by about 6-9 months, the "outcome will be definitive," said Butler, who reiterates an Outperform rating and $21 price target on Halozyme shares.
01/11/19
WELS
01/11/19
NO CHANGE
WELS
Outperform
Halozyme undervalued relative to 'de -risked' assets, says Wells Fargo
Wells Fargo analyst Jim Birchenough reiterates an Overweight rating on Halozyme Therapeutics following this week's update and 2019 outlook. The analyst continues to view the company as undervalued relative to its "highly de -risked" lead Enhanze assets. He sees "significant option value" to the broader Enhanze opportunity and PEGPH20 data.
02/05/19
PIPR
02/05/19
NO CHANGE
Target $161
PIPR
Overweight
Piper says argenx cusatuzumab study could enable registration if responses hold
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $161 price target on argenx (ARGX) after the company announced a collaboration agreement with Halozyme (HALO). In a research note to investors, Tenthoff says that an ongoing Phase II study of cusatuzumab, which was licensed to Janssen (JNJ) after demonstrating a 92% response rate in AML at ASH, could enable registration if responses hold. The company will host an R&D Day in NYC on May 16 to introduce ARGX-117 and also expects the company will introduce ARGX-118.

TODAY'S FREE FLY STORIES

RTLR

Rattler Midstream

$0.00

(0.00%)

10:43
05/23/19
05/23
10:43
05/23/19
10:43
Syndicate
Breaking Syndicate news story on Rattler Midstream »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

XLE

Energy Select Sector SPDR

$61.29

-2.23 (-3.51%)

10:40
05/23/19
05/23
10:40
05/23/19
10:40
Options
Massive ratio put spread in Energy SPDR ETF adjust profitable position »

Massive ratio put spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACAD

Acadia

$24.78

-0.33 (-1.31%)

, ALKS

Alkermes

$24.44

-0.61 (-2.44%)

10:39
05/23/19
05/23
10:39
05/23/19
10:39
Conference/Events
JPMorgan biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Fye,…

ACAD

Acadia

$24.78

-0.33 (-1.31%)

ALKS

Alkermes

$24.44

-0.61 (-2.44%)

ITCI

Intra-Cellular

$13.49

0.41 (3.13%)

NBIX

Neurocrine

$78.73

-1.14 (-1.43%)

SAGE

Sage Therapeutics

$173.51

-1.49 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 05

    Jun

  • 27

    Sep

IDYA

IDEAYA Biosciences

$0.00

(0.00%)

10:37
05/23/19
05/23
10:37
05/23/19
10:37
Syndicate
IDEAYA Biosciences indicated to open at $14, IPO priced at $10 »

IDEAYA Biosciences (IDYA)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CZR

Caesars

$8.96

-0.155 (-1.70%)

10:35
05/23/19
05/23
10:35
05/23/19
10:35
Options
Caesars put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
05/23/19
05/23
10:30
05/23/19
10:30
General news
EIA natural gas storage change for week ending May 17 »

Gas inventories 100 Bcf…

RTLR

Rattler Midstream

$0.00

(0.00%)

10:25
05/23/19
05/23
10:25
05/23/19
10:25
Syndicate
Breaking Syndicate news story on Rattler Midstream »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

10:25
05/23/19
05/23
10:25
05/23/19
10:25
Conference/Events
JPMorgan TMT analyst to hold an Analyst/Industry conference call »

TMT Sector Specialist…

AGR

Avangrid

$50.37

-0.04 (-0.08%)

10:23
05/23/19
05/23
10:23
05/23/19
10:23
Hot Stocks
Avangrid Renewables announces new wind contract with Dairyland »

Dairyland Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

AMX

America Movil, also tag AMOV

$14.15

-0.19 (-1.33%)

10:20
05/23/19
05/23
10:20
05/23/19
10:20
Options
Call buyer opens a notable new position in American Movil »

Call buyer opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$0.00

(0.00%)

, FANG

Diamondback Energy

$103.16

-5.71 (-5.24%)

10:19
05/23/19
05/23
10:19
05/23/19
10:19
Syndicate
Breaking Syndicate news story on Rattler Midstream, Diamondback Energy »

Rattler Midstream…

RTLR

Rattler Midstream

$0.00

(0.00%)

FANG

Diamondback Energy

$103.16

-5.71 (-5.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 23

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
05/23/19
05/23
10:17
05/23/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
05/23/19
05/23
10:16
05/23/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUNW

Sunworks

$0.68

0.0226 (3.42%)

10:15
05/23/19
05/23
10:15
05/23/19
10:15
Hot Stocks
Sunworks wins contract to build 1 MW solar project for California school »

Sunworks announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$0.00

(0.00%)

, FANG

Diamondback Energy

$102.97

-5.9 (-5.42%)

10:15
05/23/19
05/23
10:15
05/23/19
10:15
Syndicate
Rattler Midstream indicated to open at $17.50, IPO priced at $17.50 »

Rattler Midstream (RTLR),…

RTLR

Rattler Midstream

$0.00

(0.00%)

FANG

Diamondback Energy

$102.97

-5.9 (-5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 23

    May

TSLA

Tesla

$197.24

5.85 (3.06%)

10:15
05/23/19
05/23
10:15
05/23/19
10:15
Periodicals
Musk says Tesla produced 900 Model 3s per day this week, Reuters reports »

Tesla has produced 900…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

SBUX

Starbucks

$76.11

-1.12 (-1.45%)

10:15
05/23/19
05/23
10:15
05/23/19
10:15
Options
Starbucks put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 25

    Jun

  • 09

    Jul

10:15
05/23/19
05/23
10:15
05/23/19
10:15
General news
FX Action: The dollar »

FX Action: The dollar…

10:15
05/23/19
05/23
10:15
05/23/19
10:15
General news
Breaking General news story  »

Week of 5/17 EIA Natural…

CMG

Chipotle

$665.03

-41.02 (-5.81%)

, BLMN

Bloomin' Brands

$18.74

-1.46 (-7.23%)

10:12
05/23/19
05/23
10:12
05/23/19
10:12
On The Fly
Chipotle seen among restaurants most at risk from African swine fever pressure »

Shares of Chipotle…

CMG

Chipotle

$665.03

-41.02 (-5.81%)

BLMN

Bloomin' Brands

$18.74

-1.46 (-7.23%)

TXRH

Texas Roadhouse

$52.05

-2.96 (-5.38%)

HRL

Hormel Foods

$38.38

-1.1 (-2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 29

    May

  • 13

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 27

    Aug

  • 28

    Aug

  • 13

    Nov

ELAN

Elanco

$32.33

-0.055 (-0.17%)

, CTB

Cooper Tire

$28.35

-0.28 (-0.98%)

10:10
05/23/19
05/23
10:10
05/23/19
10:10
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ELAN

Elanco

$32.33

-0.055 (-0.17%)

CTB

Cooper Tire

$28.35

-0.28 (-0.98%)

GT

Goodyear Tire

$14.59

-0.41 (-2.73%)

SCPL

SciPlay

$15.40

-0.06 (-0.39%)

TH

Target Hospitality

$10.74

-0.06 (-0.56%)

ALLO

Allogene Therapeutics

$28.29

-0.75 (-2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

QCOM

Qualcomm

$66.24

-3 (-4.33%)

, CMG

Chipotle

$665.03

-41.02 (-5.81%)

10:10
05/23/19
05/23
10:10
05/23/19
10:10
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

QCOM

Qualcomm

$66.24

-3 (-4.33%)

CMG

Chipotle

$665.03

-41.02 (-5.81%)

BLMN

Bloomin' Brands

$18.73

-1.47 (-7.28%)

SSL

Sasol

$24.66

-0.95 (-3.71%)

EXPE

Expedia

$115.63

-1.14 (-0.98%)

NTAP

NetApp

$58.89

-3.69 (-5.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 04

    Jun

  • 06

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 31

    Jul

TGT

Target

$77.90

0.4 (0.52%)

, PM

Philip Morris

$85.84

0.38 (0.44%)

10:10
05/23/19
05/23
10:10
05/23/19
10:10
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

TGT

Target

$77.90

0.4 (0.52%)

PM

Philip Morris

$85.84

0.38 (0.44%)

BKNG

Booking Holdings

$1,726.43

-19.07 (-1.09%)

VRTX

Vertex

$171.22

-1.15 (-0.67%)

RACE

Ferrari

$141.66

-1.22 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 06

    Jun

  • 12

    Jun

10:10
05/23/19
05/23
10:10
05/23/19
10:10
General news
U.S. new home sales dropped 6.9% to 673k in April »

U.S. new home sales…

VRNT

Verint

$56.09

-5.12 (-8.36%)

10:07
05/23/19
05/23
10:07
05/23/19
10:07
Hot Stocks
Verint named Strong Sell at Spruce Point as M&A 'obscures' organic growth »

Shares of Verint (VRNT)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.